Table 3.
Abbreviations
| Term (abbreviation) | Definition |
|---|---|
| AAD | Antiarrhythmic drug |
| ACC | American College of Cardiology |
| AEF | Atrioesophageal fistula |
| AF | Atrial fibrillation |
| AFl | Atrial flutter |
| AHA | American Heart Association |
| AI | Ablation index |
| ANS | Autonomic nervous system |
| APD | Action potential duration |
| APHRS | Asia Pacific Heart Rhythm Society |
| ASD | Atrial septum defect |
| AT | Atrial tachycardia |
| ATP | Adenosine triphosphate |
| AVNRT | Atrioventricular nodal reentry tachycardia |
| AVRT | Atrioventricular reentry tachycardia |
| BMI | Body mass index |
| BP | Blood pressure |
| CABG | Coronary artery bypass graft |
| CCS | Canadian Cardiovascular Society |
| CCT | Cardiac computed tomography |
| CF | Contact force |
| CFAE | Complex fractionated atrial electrogram |
| CMR | Cardiac magnetic resonance |
| CNS | Cardiac nervous system |
| CPAP | Continuous positive airway pressure |
| CRT-D | Cardiac resynchronization therapy defibrillator |
| CS | Coronary sinus |
| CSANZ | Cardiac Society of Australia and New Zealand |
| CTI | Cavotricuspid isthmus |
| DAT | Diagnosis to ablation time |
| DOAC | Direct oral anticoagulant |
| EAM | Electroanatomical mapping |
| ECG | Electrocardiogram |
| ECGI | Electrocardiographic imaging |
| EHRA | European Heart Rhythm Association |
| ERP | Effective refractory period |
| ESC | European Society of Cardiology |
| FTI | Force time integral |
| GCV | Great cardiac vein |
| GP | Ganglionated plexi |
| HCM | Hypertrophic cardiomyopathy |
| HF | Heart failure |
| HFJV | High-frequency jet ventilation |
| HFLTV | High-frequency low tidal volume |
| HFpEF | Heart failure with preserved ejection fraction |
| HFrEF | Heart failure with reduced ejection fraction |
| HRS | Heart Rhythm Society |
| ICD | Implantable cardiac defibrillator |
| ICE | Intracardiac echocardiography |
| ICM | Implantable cardiac monitor |
| INR | International normalized ratio |
| LA | Left atrium |
| LAA | Left atrial appendage |
| LAHRS | Latin American Heart Rhythm Society |
| LAPW | Left atrial posterior wall |
| LGE | Late gadolinium enhancement |
| LoE | Level of evidence |
| LIPV | Left inferior pulmonary vein |
| LMWH | Low molecular weight heparin |
| LSI | Lesion size index |
| LSPV | Left superior pulmonary vein |
| LVEF | Left ventricular ejection fraction |
| MRI | Magnetic resonance imaging |
| OSA | Obstructive sleep apnoea |
| PFA | Pulsed field ablation |
| PFO | Patent foramen ovale |
| PN | Phrenic nerve |
| PPI | Proton pump inhibitor |
| PV | Pulmonary vein |
| PVI | Pulmonary vein isolation |
| PWI | Posterior wall isolation |
| QoL | Quality of life |
| RA | Right atrium |
| RCT | Randomized clinical trial |
| RF | Radiofrequency |
| RSPV | Right superior pulmonary vein |
| SVC | Superior vena cava |
| SVT | Supraventricular tachycardia |
| TEE | Transesophageal echocardiography |
| TIA | Transient ischemic attack |
| TTI | Time to isolation |
| UFH | Unfractionated heparin |
| VKA | Vitamin K antagonist |
| VoM | Vein of Marshall |